日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

EBNA1 SUMOylation by PIAS1 suppresses EBV lytic replication and enhances episome maintenance.

PIAS1 对 EBNA1 的 SUMO 化作用抑制 EBV 裂解性复制并增强游离体维持。

Sugiokto Febri Gunawan, Zhang Kun, Maharjan Yunash, Li Renfeng

Targeting EBV Episome for Anti-Cancer Therapy: Emerging Strategies and Challenges

靶向EBV游离体抗癌疗法:新兴策略与挑战

Sugiokto, Febri Gunawan; Li, Renfeng

EBNA1 SUMOylation by PIAS1 Suppresses EBV Lytic Replication and Enhances Episome Maintenance.

PIAS1 对 EBNA1 的 SUMO 化作用抑制 EBV 裂解性复制并增强游离体维持。

Sugiokto Febri Gunawan, Zhang Kun, Li Renfeng

Targeted eradication of EBV-positive cancer cells by CRISPR/dCas9-mediated EBV reactivation in combination with ganciclovir

通过 CRISPR/dCas9 介导的 EBV 再激活与更昔洛韦联合靶向消灭 EBV 阳性癌细胞

Febri Gunawan Sugiokto, Renfeng Li

Caspases Switch off the m6A RNA Modification Pathway to Foster the Replication of a Ubiquitous Human Tumor Virus

半胱天冬酶关闭m6A RNA修饰途径以促进普遍存在的人类肿瘤病毒的复制

Kun Zhang ,Yucheng Zhang ,Yunash Maharjan ,Febri Gunawan Sugiokto ,Jun Wan ,Renfeng Li

Phage φAB6-Borne Depolymerase Combats Acinetobacter baumannii Biofilm Formation and Infection

噬菌体φAB6携带的解聚酶抵抗鲍曼不动杆菌生物膜的形成和感染

Md Shahed-Al-Mahmud, Rakesh Roy, Febri Gunawan Sugiokto, Md Nazmul Islam, Ming-Der Lin, Ling-Chun Lin, Nien-Tsung Lin